Sex differences in the association between plasma copeptin and incident type 2 diabetes: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study

Advances in Measuring the Effect of Individual Predictors of Cardiovascular Risk: The Role of Reclassification Measures

(2013) Nancy R. Cook et al.   ANNALS OF INTERNAL MEDICINE

Analysis of sex and gender-specific research reveals a common increase in publications and marked differences between disciplines

(2012) Sabine Oertelt-Prigione et al.   BMC Medicine

Developing risk prediction models for type 2 diabetes: a systematic review of methodology and reporting

(2011) Gary S Collins et al.   BMC Medicine

Biomarkers for the Prediction of Type 2 Diabetes and Cardiovascular Disease

(2011) C Herder et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Plasma procalcitonin and risk of type 2 diabetes in the general population

(2011) A. Abbasi et al.   DIABETOLOGIA

Risk Assessment Tools for Identifying Individuals at Risk of Developing Type 2 Diabetes

(2011) B. Buijsse et al.   EPIDEMIOLOGIC REVIEWS

Sex Differences in the Effects of MDMA (Ecstasy) on Plasma Copeptin in Healthy Subjects

(2011) Linda D. Simmler et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Plasma Copeptin, A Unifying Factor behind the Metabolic Syndrome

(2011) Sofia Enhörning et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Plasma Copeptin and the Risk of Diabetes Mellitus

(2010) Sofia Enhörning et al.   CIRCULATION

Thirty-One Novel Biomarkers as Predictors for Clinically Incident Diabetes

(2010) Veikko Salomaa et al.   PLoS One

Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers

(2010) Michael J. Pencina et al.   STATISTICS IN MEDICINE

Both V1A and V1B vasopressin receptors deficiency result in impaired glucose tolerance

(2009) Kazuaki Nakamura et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Plasma Carboxy-Terminal Provasopressin (Copeptin): A Novel Marker of Insulin Resistance and Metabolic Syndrome

(2009) Umer Saleem et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Copeptin, a surrogate marker of vasopressin, is associated with microalbuminuria in a large population cohort

(2009) Esther Meijer et al.   KIDNEY INTERNATIONAL

Albuminuria Assessed From First-Morning-Void Urine Samples Versus 24-Hour Urine Collections as a Predictor of Cardiovascular Morbidity and Mortality

(2008) H. J. Lambers Heerspink et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Assessing New Biomarkers and Predictive Models for Use in Clinical Practice

(2008) Kevin McGeechan et al.   ARCHIVES OF INTERNAL MEDICINE

Gender and renal function influence plasma levels of copeptin in healthy individuals

(2008) Sanjay S. Bhandari et al.   CLINICAL SCIENCE

Predicting Diabetes: Clinical, Biological, and Genetic Approaches: Data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR)

(2008) B. Balkau et al.   DIABETES CARE

Copeptin in the Differential Diagnosis of Hyponatremia

(2008) Wiebke Fenske et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Urinary albumin excretion is a risk factor for diabetes mellitus in men, independently of initial metabolic profile and development of insulin resistance. The DESIR Study

(2008) Jean-Michel Halimi et al.   JOURNAL OF HYPERTENSION